R&D Day | INSM Message Board Posts

Insmed Incorporated

  INSM website

INSM   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  53534 of 55728  at  9/25/2020 12:50:03 PM  by

JAD9000


 In response to msg 53533 by  brewcrew
view thread

Re: R&D Day

Long term risk has switched from being long to being short. As results from EU approval, Japan approval and various trial data for Brensocatib (Covid, Bronchiectasis, Asthma, COPD, etc.) roll in the benefit vs liability continues to accelerate.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 2     Views: 321
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board








Financial Market Data provided by
.
Loading...